Evidence map›Paper›PMID 18438408›Full record

ArticleNature genetics2008

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing.

Peter J Campbell, Philip J Stephens, Erin D Pleasance, Sarah O'Meara, Heng Li, Thomas Santarius, Lucy A Stebbings, Catherine Leroy, Sarah Edkins, Claire Hardy and 14 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 426 papers.

0numbers the graph read from it
0cells of the map it votes in
426citing papers in PubMed
38.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01858649 phase2completednot on this mapstarted 2013, after this paper: background citation

Randomized Phase 2 Study Comparing Pathological Responses on Colorectal Cancer Metastases After Preoperative Treatment Combining Bevacizumab With FOLFOX or FOLFIRI

TypeinterventionalSponsorCliniques universitaires Saint-Luc- Université Catholique de LouvainRan2013 to 2019Enrolled60ConditionsMetastatic Colorectal CancerArmsMetastases resection, Bevacizumab, 5 FU, Oxaliplatin, Irinotecan
NCT01858662 phase2terminatednot on this mapstarted 2014, after this paper: background citation

Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

TypeinterventionalSponsorCliniques universitaires Saint-Luc- Université Catholique de LouvainRan2014 to 2015Enrolled4ConditionsMetastatic Colorectal CancerArmsMetastases Resection ( multiple steep surgery possible), 5-Fluorouracile, leucovorin L, Oxaliplatin, Irinotecan
3 · Its place in the literature

Who cites it

426 citing papers in PubMed, 830 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology.International journal of molecular sciences · 2025
    Review
  6. Oncogenic gene fusions in cancer: from biology to therapy.Signal transduction and targeted therapy · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The reckoning of chromosomal instability: past, present, future.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Preleukemic Fusion Genes Induced via Ionizing Radiation.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article

366 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 2 institutions in 1 country.

Peter J CampbellWellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Philip J Stephens
Erin D Pleasance
Sarah O'Meara
Heng Li
Thomas Santarius
Lucy A Stebbings
Catherine Leroy
Sarah Edkins
Claire Hardy
Jon W Teague
Andrew Menzies
Ian Goodhead
Daniel J Turner
Christopher M Clee
Michael A Quail
Antony Cox
Clive Brown
Richard Durbin
Matthew E Hurles
Paul A W Edwards
Graham R Bignell
Michael R Stratton
P Andrew Futreal
Wellcome Sanger Institute · GBUniversity of Cambridge · GB

Funding

Wellcome Trust 077012Wellcome Trust 088340
6 · The paper itself

Abstract

Human cancers often carry many somatically acquired genomic rearrangements, some of which may be implicated in cancer development. However, conventional strategies for characterizing rearrangements are laborious and low-throughput and have low sensitivity or poor resolution. We used massively parallel sequencing to generate sequence reads from both ends of short DNA fragments derived from the genomes of two individuals with lung cancer. By investigating read pairs that did not align correctly with respect to each other on the reference human genome, we characterized 306 germline structural variants and 103 somatic rearrangements to the base-pair level of resolution. The patterns of germline and somatic rearrangement were markedly different. Many somatic rearrangements were from amplicons, although rearrangements outside these regions, notably including tandem duplications, were also observed. Some somatic rearrangements led to abnormal transcripts, including two from internal tandem duplications and two fusion transcripts created by interchromosomal rearrangements. Germline variants were predominantly mediated by retrotransposition, often involving AluY and LINE elements. The results demonstrate the feasibility of systematic, genome-wide characterization of rearrangements in complex human cancer genomes, raising the prospect of a new harvest of genes associated with cancer using this strategy.

Indexed as

Genome, HumanSequence Analysis, DNABase PairingChromosome MappingComputational BiologyGene DosageGene RearrangementGenetic VariationHumansLung NeoplasmsRepetitive Sequences, Nucleic AcidReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Messenger

Identifiers

PMID18438408
PMCPMC2705838
OpenAlexW2108698786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.